The ratings of 6 Health Care Equipment & Supplies stocks are down this week, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
This week, Exactech, Inc. (EXAC) drops from a C to a D rating. Exactech, Inc. develops, manufactures, markets, and sells orthopedic implant devices and related surgical instrumentation. For more information, get Portfolio Grader’s complete analysis of EXAC stock.
GenMark Diagnostics, Inc. (GNMK) earns a F this week, moving down from last week’s grade of D. GenMark Diagnostics, Inc. is a molecular diagnostics company focused on developing and commercializing its biomarker detection technology. The company also gets F’s in earnings surprise, return on equity, and free cash flow. For more information, get Portfolio Grader’s complete analysis of GNMK stock.
Volitionrx Limited (VNRX) is having a tough week. The company’s rating falls from a C to a D. The company also gets F’s in sales growth and return on equity. For more information, get Portfolio Grader’s complete analysis of VNRX stock.
CryoPort, Inc.’s (CYRX) rating weakens this week, dropping to a D versus last week’s C. The company also gets F’s in return on equity and free cash flow. For more information, get Portfolio Grader’s complete analysis of CYRX stock.
Akers Biosciences, Inc. (AKER) experiences a ratings drop this week, going from last week’s C to a D. The company also gets F’s in sales growth, return on equity, and free cash flow. For more information, get Portfolio Grader’s complete analysis of AKER stock.
This week, STRATA Skin Sciences, Inc.’s (SSKN) rating worsens to a F from the company’s C rating a week ago. The company also gets F’s in earnings surprise, return on equity, and free cash flow. For more information, get Portfolio Grader’s complete analysis of SSKN stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
